Proliferation assays are crucial for understanding cell growth dynamics, drug efficacy, immune function, and toxicity testing. Accelevir Diagnostics offers these assays to study cell division rates, evaluate drug impacts, and assess immune cell responses. Discover how proliferation assays can drive your research in cancer, immunotherapy, and disease mechanisms. #ProliferationAssays #CellGrowth #CancerResearch #Immunology 🔬 Learn more about Accelevir's proliferation assays at https://lnkd.in/eha7qVYP
About us
Accelevir Diagnostics is a growing Maryland biotechnology company creating innovative assays for ultra-rare analytes in infectious disease and beyond. With expertise spanning virology, immunology, genomics and cell and gene therapy, our team develops, scales, and commercializes complex assay workflows to support our biopharma partners from basic research through clinical trials. We are currently focused on advancing new assays for persistent HIV-1 and other clinically important viral infections. To date, we have received over $15M in federal, state and private funding to advance our assays. We are actively working with leading academic and bio-pharma groups to provide our assays in support of translational research and early-stage clinical trials aimed at developing game-changing therapeutics with the potential to cure chronic viral infections.
- Website
-
http://www.accelevirdx.com
External link for Accelevir Diagnostics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Baltimore, Maryland
- Type
- Privately Held
- Specialties
- HIV/AIDS, Virology, Genomics, Immunology, Digital PCR, CRO Assay Services, and Assay Validation/Verification
Locations
-
Primary
Get directions
701 E Pratt St
Baltimore, Maryland 21202, US
Employees at Accelevir Diagnostics
-
Greg Laird
Virologist and Biotech Entrepreneur
-
Hannah MacLeod
Lead Scientist at Accelevir specializing in novel dPCR and NGS assay development for advanced viral diagnostics.
-
Bobbi Urban
MB (ASCP)CM | LSS Green Belt | Molecular Diagnostics | Clinical Operations | Laboratory Management | Regulatory Compliance | Pinball Enthusiast
-
Daniel Grun
Team Lead - Immunology Services
Updates
-
Discover how Accelevir Diagnostics supports functional cell-based assays using flow cytometry, covering mechanisms like proliferation and cytotoxicity. #CustomPhenotyping #FlowCytometryServices #CellAnalysis 🧬 Explore more at https://lnkd.in/eha7qVYP
-
-
Accelevir Diagnostics' flow cytometry services provide custom phenotyping panels in just two weeks, including T and B cell analysis. #FlowCytometry #Phenotyping #CytotoxicityAssays 💡 Learn more at https://lnkd.in/eha7qVYP
-
-
Accelevir Diagnostics reposted this
Happy National STEM Day! 🧬🔬 Today, we celebrate the innovators, creators, and trailblazers in STEM who are shaping the discoveries of tomorrow! #STEM #lifesciences #science
-
-
Throwback to the Crab Trap: Celebrating Cerillo’s Innovation in Microbiome Research BioHealth Innovation, Inc. (BHI) led another great year of the 10th Annual BioHealth Capital Region Forum and the 9th Annual Crab Trap Competition. Accelevir Diagnostics is thrilled to celebrate Cerillo, a Charlottesville, VA-based company, who earned $10,000 in CRO services, sponsored by both Accelevir Diagnostics and Noble Life Sciences Inc, said Albine Martin, PhD, Co-Founder and Managing Director of Accelevir Diagnostics, who also served as a Crab Trap judge. “The Crab Trap is an incredible platform for showcasing innovation, and we are thrilled to support Cerillo as they work to advance microbiome research. Congratulations to Eric and the Cerillo team—we’re excited to partner with you on this important journey.” She further noted, "It takes a village," and this year's BioHealth Capital Region Forum continues to highlight the momentum and collaboration opportunities to support companies within our community.
-
-
Uncover Anti-Drug Antibodies - Explore Accelevir Diagnostics' #immunogenicity testing services, including assays for anti-drug and neutralizing #antibodies (#NAb). #ImmunogenicityTesting #TherapeuticResearch #NeutralizingAntibodies 🌐 Learn more at https://lnkd.in/eha7qVYP
-
-
Accelevir Diagnostics' ELISpot and FluoroSpot services detect T and B cell targets for multiple species. #TCellResearch #BCellAssays #Immunology 🧪 Discover more at https://lnkd.in/eha7qVYP
-
-
Accelevir Diagnostics provides assays for lymphokines and chemokines with current offerings like #HIV-1 P24 and LAg-avidity. Discover the potential for rapid expansion. #BiomarkerAnalysis #InfectiousDisease #AssayDevelopment 🔍 Learn more at https://lnkd.in/eha7qVYP
-
-
Expand Your Research Potential Learn about Accelevir Diagnostics' quantitative assays for protein analysis, including #HIV-1 P24 and LAg-avidity. Accelevir's offerings can expand to various human, rodent, NHP, and pig protein targets. #QuantitativeAssays #ProteinAnalysis #InfectiousDiseaseResearch ➡️ Find out more at https://lnkd.in/eha7qVYP
-
-
💡 Conserved patterns, global solutions At the heart of #HIV-1 cure research is the ability to distinguish between intact and defective proviruses. Dr. Hannah MacLeod’s latest work, presented at #CROI2024, highlights AccelevirDx’s advances in #sequencing technology, showing consistent proviral landscapes across Group M. This research supports the global application of IPDA® Version 2, driving us closer to a unified HIV-1 cure effort. 📍 Learn more about her cutting-edge findings https://bit.ly/3TghsBT
-